Alterity Therapeutics (ATHE) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free ATHE Stock Alerts $2.01 +0.01 (+0.50%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Reviewglobenewswire.com - May 8 at 7:25 AMAppendix 4C – Q3 FY24 Quarterly Cash Flow Reportglobenewswire.com - April 30 at 7:25 AMAlterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxiafinance.yahoo.com - April 29 at 7:54 AMAlterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich's Ataxiaglobenewswire.com - April 29 at 7:25 AMAlterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meetingfinance.yahoo.com - April 17 at 8:21 AMAlterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024globenewswire.com - April 10 at 7:25 AMAlterity Therapeutics Limited (ATHE)finance.yahoo.com - April 5 at 12:19 PMAlterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refundglobenewswire.com - March 26 at 10:25 AMAlterity Therapeutics Ltd ADR ATHEmorningstar.com - March 24 at 11:05 PMATHE Alterity Therapeutics Limitedseekingalpha.com - March 22 at 9:44 PMAlterity Therapeutics Ltd. ADRwsj.com - March 22 at 9:44 PMAlterity Therapeutics drops on capital raisemsn.com - February 23 at 1:58 PMAlterity Therapeutics Stock (NASDAQ:ATHE), Short Interest Reportbenzinga.com - February 22 at 7:35 AMmarketbeat.com - February 21 at 5:42 PMAlterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meetingfinance.yahoo.com - February 20 at 4:16 PMAlterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meetingglobenewswire.com - February 20 at 10:25 AMAlterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Weekfinance.yahoo.com - January 29 at 10:07 AMAlterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestonesfinance.yahoo.com - January 22 at 9:05 AMALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officerfinanznachrichten.de - December 21 at 10:07 AMAlterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progressfinance.yahoo.com - December 4 at 7:16 PMAlterity Therapeutics Shares Up Fivefold on New Parkinson's Drug Datamarketwatch.com - December 4 at 2:16 PMWhy Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today?msn.com - December 4 at 2:16 PMBiotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Datafinance.yahoo.com - December 4 at 2:16 PMAlterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Diseasefinance.yahoo.com - December 4 at 8:15 AMAlterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophyfinance.yahoo.com - November 27 at 8:57 AMAlterity Therapeutics Limited's (ASX:ATH) CEO Compensation Is Looking A Bit Stretched At The Momentfinance.yahoo.com - November 22 at 8:08 PMAlterity Therapeutics, Edesa Biotech among healthcare moversmsn.com - November 22 at 3:07 PMAlterity Therapeutics ADRs Shares Dive 31% on Raised Capitalmarketwatch.com - November 22 at 3:07 PMmarketbeat.com - November 20 at 6:37 AMALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434finanznachrichten.de - November 16 at 9:22 AMAlterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434finance.yahoo.com - November 16 at 9:22 AMALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophyfinanznachrichten.de - November 8 at 10:47 AMAppendix 4C – Q1 FY24 Quarterly Cash Flow Reportfinance.yahoo.com - October 30 at 12:00 PMAlterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorderfinance.yahoo.com - August 31 at 8:54 AMAlterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’sfinance.yahoo.com - August 23 at 8:45 AMAlterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson's Disease and Movement Disorderstechnews.tmcnet.com - August 22 at 5:14 PMAlterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disordersfinance.yahoo.com - August 22 at 5:14 PMAlterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refundfinance.yahoo.com - August 15 at 7:49 AMAppendix 4C – Q4 FY23 Quarterly Cash Flow Reportfinance.yahoo.com - July 31 at 10:36 AMAlterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plannedfinance.yahoo.com - July 26 at 9:27 PMAlterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023finance.yahoo.com - June 21 at 8:14 AMAlterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorderfinance.yahoo.com - May 30 at 12:00 PMAlterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023finance.yahoo.com - May 19 at 8:54 AMAppendix 4C – Q3 FY23 Quarterly Cash Flow Reportfinance.yahoo.com - May 10 at 12:04 PMAlterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophyfinance.yahoo.com - May 10 at 12:04 PMAlterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurologyfinance.yahoo.com - April 26 at 7:42 AMAlterity gets US patent, inks licensing pact to advance asset for Alzheimer'smsn.com - March 14 at 9:24 AMAlterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Diseasefinance.yahoo.com - March 14 at 9:24 AMAlterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophyfinance.yahoo.com - March 8 at 10:12 AMAppendix 4C - Q2 FY23 Quarterly Cash Flow Reportfinance.yahoo.com - January 31 at 10:21 AM Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. ATHE Media Mentions By Week ATHE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATHE News Sentiment▼0.940.44▲Average Medical News Sentiment ATHE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATHE Articles This Week▼30▲ATHE Articles Average Week Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CMMB News Today AEZS News Today ADXN News Today GRTX News Today GHSI News Today MTEM News Today ERNA News Today ABVC News Today MIRA News Today MBRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATHE) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
